Literature DB >> 10657735

Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.

B M Kudielka1, A K Schmidt-Reinwald, D H Hellhammer, C Kirschbaum.   

Abstract

In this placebo-controlled double-blind study, psychological and endocrine stress responses were investigated in healthy postmenopausal placebo-treated women (n = 15; 60-75 years; placebo via transdermal patches), healthy postmenopausal estradiol-treated women (n = 13; 60-79 years; 0.1 mg 17beta-estradiol daily via transdermal patches) and young controls (n = 15; 20-31 years; untreated). The aged subjects received estradiol or placebo treatment for 14 days. All subjects were then exposed to the 'Trier Social Stress Test' (TSST) and the dexamethasone (Dex)-human corticotropin-releasing hormone (hCRH) test (100 microgram hCRH after premedication with 1.5 mg Dex). Psychological parameters including perceived stressfulness, mood and subjective well-being were measured by visual analog scales, a mood questionnaire and a mood diary, respectively. Results show that the TSST induced significant increases in adrenocorticotropin (ACTH), free salivary cortisol, total plasma cortisol and heart rates (all p < 0.0001). Regardless of age, comparable hormonal response patterns were observed in the TSST as indicated by similar peak levels and recovery phases. Visual analog scales confirmed that the same amount of stress was experienced by young and elderly subjects. In both age groups, hCRH injection after Dex premedication provoked significant increases in ACTH, free salivary cortisol and total plasma cortisol (all p < 0.0001). In contrast to the psychosocial stressor, elderly women were found to respond with a markedly enhanced cortisol response compared to young controls in the Dex-CRH test (p < 0.025). Additional investigation of morning cortisol profiles could not reveal any age-related differences in basal hypothalamus-pituitary-adrenal (HPA) axis activity. Following estradiol treatment, estradiol levels significantly increased only in substituted postmenopausal women (p < 0.001) reaching concentrations typically found in younger women during the follicular phase of the menstrual cycle. Corticosteroid-binding globulin levels did not differ significantly between groups. When confronted with the TSST, no response differences emerged between the three groups. However, estradiol treatment appeared to blunt the total plasma cortisol response in the Dex-CRH test, resulting in smaller increases in untreated premenopausal women and estradiol-treated postmenopausal women compared to placebo-treated postmenopausal women (p < 0.02). In sum, no response differences were observed after confrontation with a psychosocial stress test in our sample of healthy elderly subjects. As shown with the Dex-CRH test, our data suggest that the negative feedback of the HPA axis in elderly women is altered. Moreover, the current data suggest that estradiol replacement may modulate HPA feedback sensitivity in humans. Copyright 1999 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10657735     DOI: 10.1159/000054504

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  35 in total

Review 1.  Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism.

Authors:  W M Kohrt; R E Van Pelt; W S Gozansky
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 3.  Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease.

Authors:  Kathi L Heffner
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 4.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

5.  3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Authors:  Elaine K Hebda-Bauer; Tracy A Simmons; Andrew Sugg; Eren Ural; James A Stewart; James L Beals; Qiang Wei; Stanley J Watson; Huda Akil
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Stress, inflammation, and aging.

Authors:  Helen Lavretsky; Paul A Newhouse
Journal:  Am J Geriatr Psychiatry       Date:  2012-09       Impact factor: 4.105

7.  The effect of long-term ovariectomy on midbrain stress systems in free ranging macaques.

Authors:  Cynthia L Bethea; Arubala P Reddy
Journal:  Brain Res       Date:  2012-10-01       Impact factor: 3.252

8.  Estradiol, but not testosterone, heightens cortisol-mediated negative feedback on pulsatile ACTH secretion and ACTH approximate entropy in unstressed older men and women.

Authors:  Animesh N Sharma; Paul Aoun; Jean R Wigham; Suanne M Weist; Johannes D Veldhuis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-26       Impact factor: 3.619

9.  Differential heart rate reactivity and recovery after psychosocial stress (TSST) in healthy children, younger adults, and elderly adults: the impact of age and gender.

Authors:  Brigitte M Kudielka; Angelika Buske-Kirschbaum; Dirk H Hellhammer; Clemens Kirschbaum
Journal:  Int J Behav Med       Date:  2004

Review 10.  Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

Authors:  Johannes D Veldhuis; Animesh Sharma; Ferdinand Roelfsema
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-13       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.